Abstract
BL-S640, a new oral cephalosporin analogue, was evaluated in vitro against 102 gram-negative and 80 gram-positive bacteria. The antimicrobial spectrum was similar to that of previous cephalosporin analogues. Good antimicrobial activity against strains of Escherichia coli, Klebsiella, staphylococci, and streptococci was demonstrated. Relatively poor activity and/or resistance was noted among most strains of Proteus, Providencia, Pseudomonas, and Serratia. In comparative studies BL-S640 had better activity against strains of Hemophilus influenzae, Staphylococcus aureus, and Enterobacteriaceae than many cephalosporin analogues. Variation of susceptibility results was dependent upon the type of media and inoculum size. Cross-resistance between BL-S640 cephalexin, cephalothin, and cefazolin was demonstrated. Among strains of Klebsiella the more rapid selection of resistance ot other cephalosporins was in contrast to BL-S640. Experience in vitro with BL-S640 has documented its antimicrobial activity,and further studies of pharmacokinetics and therapeutic efficacy are indicated.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BONIECE W. S., WICK W. E., HOLMES D. H., REDMAN C. E. In vitro and in vivo laboratory evaluation of cephalothin, a new broad spectrum antibiotic. J Bacteriol. 1962 Dec;84:1292–1296. doi: 10.1128/jb.84.6.1292-1296.1962. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Eykyn S., Jenkins C., King A., Phillips I. Antibacterial activity of cefamandole, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cephalexin. Antimicrob Agents Chemother. 1973 Jun;3(6):657–661. doi: 10.1128/aac.3.6.657. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Finland M. Oral and parenteral cephalosporins: the place of cephalexin in antibacterial therapy. Drugs. 1972;3(1):1–8. doi: 10.2165/00003495-197203010-00001. [DOI] [PubMed] [Google Scholar]
- Johnson W. D., Applestein J. M., Kaye D. Cephaloglycin. Clinical and laboratory experience with an orally administered cephalosporin. JAMA. 1968 Dec 16;206(12):2698–2702. doi: 10.1001/jama.206.12.2698. [DOI] [PubMed] [Google Scholar]
- Klastersky J., Daneau D., Weerts D. Cephradine. Antibacterial activity and clinical effectiveness. Chemotherapy. 1973;18(3):191–204. doi: 10.1159/000221261. [DOI] [PubMed] [Google Scholar]
- Levison M. E., Johnson W. D., Thornhill T. S., Kaye D. Clinical and in vitro evaluation of cephalexin. A new orally administered cephalosporin antibiotic. JAMA. 1969 Sep 1;209(9):1331–1336. [PubMed] [Google Scholar]
- Ries K., Levison M. E., Kaye D. Clinical and in vitro evaluation of cefazolin, a new cephalosporin antibiotic. Antimicrob Agents Chemother. 1973 Feb;3(2):168–174. doi: 10.1128/aac.3.2.168. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sabath L. D., Wilcox C., Garner C., Finland M. In vitro activity of cefazolin against recent clinical bacterial isolates. J Infect Dis. 1973 Oct;128(Suppl):S320–S326. doi: 10.1093/infdis/128.supplement_2.s320. [DOI] [PubMed] [Google Scholar]
- TURCK M., ANDERSON K. N., SMITH R. H., WALLACE J. F., PETERSDORF R. G. LABORATORY AND CLINICAL EVALUATION OF A NEW ANTIBIOTIC--CEPHALOTHIN. Ann Intern Med. 1965 Aug;63:199–211. doi: 10.7326/0003-4819-63-2-199. [DOI] [PubMed] [Google Scholar]
- WICK W. E., BONIECE W. S. IN VITRO AND IN VIVO LABORATORY EVALUATION OF CEPHALOGLYCIN AND CEPHALORIDINE. Appl Microbiol. 1965 Mar;13:248–253. doi: 10.1128/am.13.2.248-253.1965. [DOI] [PMC free article] [PubMed] [Google Scholar]